arrow_back Trending Legislation
Share share

Medicare Lab Test Simplification: New Rules and Payments

This bill aims to simplify how medical laboratories report data to the Medicare program, potentially reducing their administrative burden. These changes could affect the availability and cost of certain laboratory tests, as well as the stability of payments to laboratories, indirectly impacting patients using Medicare.
Key points
Introduction of statistical sampling for widely available laboratory tests, meaning not all laboratories will need to report full data, reducing bureaucracy.
Delay and change in reporting period frequency for laboratories, giving them more time to adapt to new requirements.
Modification of payment reduction limits and introduction of payment increase caps for laboratory tests, aiming to stabilize rates for laboratories.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Saving Access to Laboratory Services Act
Print number: HR 2377
Sponsor: Rep. Hudson, Richard [R-NC-9]
Process start date: 2023-03-29
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Medicare Lab Test Simplification: New Rules and Payments

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 2377.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • Introduction of statistical sampling for widely available laboratory tests, meaning not all laboratories will need to report full data, reducing bureaucracy.
  • Delay and change in reporting period frequency for laboratories, giving them more time to adapt to new requirements.
  • Modification of payment reduction limits and introduction of payment increase caps for laboratory tests, aiming to stabilize rates for laboratories.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Hudson, Richard [R-NC-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Trade.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HR 2377

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health